Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

17

Revenue 2017

Allergan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Allergan's 2013 CNS (central nervous system) sales performance.

Gilead’s NASH hopes crushed as candidates fail again

Gilead’s NASH hopes crushed as candidates fail again As well as Novartis, other major pharma companies including Pfizer, Allergan, Merck &Co and Bristol-Myers Squibb are pursuing treatments in NASH.

Roche to close $4.3bn Spark deal after FTC clearance

Roche to close $4.3bn Spark deal after FTC clearance AbbVie said that there are “a few small product overlaps that we've agreed to divest promptly” ahead of its acqusition of Allergan to gain the FTC all-clear.

Sage slides off a MOUNTAIN as depression drug flunks trial

Sage slides off a MOUNTAIN as depression drug flunks trial Shortly after Spravato was approved, Allergan’s late-stage candidate  rapastinel – a weekly injectable drug targeting NMDA – bombed in three phase 3 trials.

CymaBay Therapeutics plummets after abandoning NASH drug

CymaBay Therapeutics plummets after abandoning NASH drug Other major pharma players looking to break into the NASH market first include Pfizer, Novartis, Allergan, Merck &Co and Bristol-Myers Squibb.

AbbVie sells $30bn of bonds ahead of Allergan merger

AbbVie sells $30bn of bonds ahead of Allergan merger AbbVie has sold $30bn worth of bonds to help fund its acquisition of Allergan, which was announced in in June this year. . ... The Allergan deal, he maintained, has a different purpose – to allow AbbVie to gain “critical mass” in its growth

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Planning your clinical trial? Why you need to engage patients sooner
It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....
AI and life sciences
AI: the smart money is on the smart thinking
Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...

Infographics